Fabrizio Conti

Pubblicazioni

Titolo Pubblicato in Anno
Application of ultrasound in the assessment of oligoarticular psoriatic arthritis subset. results from patients treated with apremilast ISRAEL MEDICAL ASSOCIATION JOURNAL 2021
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement JOINT BONE SPINE 2021
Comment on. real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway RHEUMATOLOGY 2021
Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjögren's syndrome ARTHRITIS & RHEUMATOLOGY 2021
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population JOURNAL OF IMMUNOLOGY RESEARCH 2021
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative Antiphospholipid Syndrome RHEUMATOLOGY 2021
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2021
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) EUROPEAN RESPIRATORY JOURNAL 2021
Perceived Disease Activity in Rheumatoid Arthritis: When the Physician's Gender Matters ISRAEL MEDICAL ASSOCIATION JOURNAL 2021
Erosive arthritis in systemic lupus erythematosus: not only Rhupus LUPUS 2021
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab. a case report RHEUMATOLOGY 2021
Response to: `correspondence on `{SARS}-{CoV}-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists'' by smerilli et al ANNALS OF THE RHEUMATIC DISEASES 2021
Protenuria in SLE:. is it always lupus LUPUS 2021
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view ANNALS OF THE RHEUMATIC DISEASES 2020
COVID-19. an unexpected indication for anti-rheumatic therapies RHEUMATOLOGY 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis. a real-life multicenter study EXPERT OPINION ON BIOLOGICAL THERAPY 2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients JOURNAL OF AUTOIMMUNITY 2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica SCIENTIFIC REPORTS 2020
Targeting the immune system for pulmonary iInflammation and cardiovascular complications in COVID-19 patients FRONTIERS IN IMMUNOLOGY 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells EBIOMEDICINE 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma